Brief: Versant Venture Capital VI L.P. Reports 9.3% Stake In Repare Therapeutics
July 7 (Reuters) - Repare Therapeutics Inc RPTX.O :
* VERSANT VENTURE CAPITAL VI L.P. REPORTS 9.3% STAKE IN
REPARE
THERAPEUTICS AS OF JUNE 23 - SEC FILING
* VERSANT VENTURE CAPITAL VI L.P. SAYS PURCHASED SECURITIES
OF
REPARE WITH AIM OF INCREASING VALUE OF FUND'S INVESTMENTS &
REPARE
Source text for Eikon: [ID: https://bit.ly/2VVUQZF]
Further company coverage: RPTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Repare Therapeutics
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Repare Therapeutics Announces Acquisition Of Polθ ATPase Inhibitor, RP-3467, By Gilead Sciences For Up To $30 Million In Total Consideration
Brief: Repare Signs Support Agreements With Key Shareholders For Xenotherapeutics Deal
Repare Therapeutics Q2 net loss narrows to $16.7 mln